Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.
Recent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials Consortium Study 28, conducted in Brazil, Ca...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-05-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010753&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850236461167673344 |
|---|---|
| author | Payam Nahid Erin E Bliven Elizabeth Y Kim William R Mac Kenzie Jason E Stout Lois Diem John L Johnson Sebastien Gagneux Philip C Hopewell Midori Kato-Maeda Tuberculosis Trials Consortium |
| author_facet | Payam Nahid Erin E Bliven Elizabeth Y Kim William R Mac Kenzie Jason E Stout Lois Diem John L Johnson Sebastien Gagneux Philip C Hopewell Midori Kato-Maeda Tuberculosis Trials Consortium |
| author_sort | Payam Nahid |
| collection | DOAJ |
| description | Recent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials Consortium Study 28, conducted in Brazil, Canada, South Africa, Spain, Uganda and the United States, and secondarily explored the relationship between lineage, clinical presentation and response to treatment. Large sequence polymorphisms and single nucleotide polymorphisms were analyzed to determine lineage and sublineage of isolates. Of 306 isolates genotyped, 246 (80.4%) belonged to the Euro-American lineage, with sublineage 724 predominating at African sites (99/192, 51.5%), and the Euro-American strains other than 724 predominating at non-African sites (89/114, 78.1%). Uneven distribution of lineages across regions limited our ability to discern significant associations, nonetheless, in univariate analyses, Euro-American sublineage 724 was associated with more severe disease at baseline, and along with the East Asian lineage was associated with lower bacteriologic conversion after 8 weeks of treatment. Disease presentation and response to drug treatment varied by lineage, but these associations were no longer statistically significant after adjustment for other variables associated with week-8 culture status. |
| format | Article |
| id | doaj-art-fbfe95ea32f94d6aa5c392ca558c021a |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2010-05-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-fbfe95ea32f94d6aa5c392ca558c021a2025-08-20T02:01:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-05-0155e1075310.1371/journal.pone.0010753Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis.Payam NahidErin E BlivenElizabeth Y KimWilliam R Mac KenzieJason E StoutLois DiemJohn L JohnsonSebastien GagneuxPhilip C HopewellMidori Kato-MaedaTuberculosis Trials ConsortiumRecent studies suggest that M. tuberculosis lineage and host genetics interact to impact how active tuberculosis presents clinically. We determined the phylogenetic lineages of M. tuberculosis isolates from participants enrolled in the Tuberculosis Trials Consortium Study 28, conducted in Brazil, Canada, South Africa, Spain, Uganda and the United States, and secondarily explored the relationship between lineage, clinical presentation and response to treatment. Large sequence polymorphisms and single nucleotide polymorphisms were analyzed to determine lineage and sublineage of isolates. Of 306 isolates genotyped, 246 (80.4%) belonged to the Euro-American lineage, with sublineage 724 predominating at African sites (99/192, 51.5%), and the Euro-American strains other than 724 predominating at non-African sites (89/114, 78.1%). Uneven distribution of lineages across regions limited our ability to discern significant associations, nonetheless, in univariate analyses, Euro-American sublineage 724 was associated with more severe disease at baseline, and along with the East Asian lineage was associated with lower bacteriologic conversion after 8 weeks of treatment. Disease presentation and response to drug treatment varied by lineage, but these associations were no longer statistically significant after adjustment for other variables associated with week-8 culture status.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010753&type=printable |
| spellingShingle | Payam Nahid Erin E Bliven Elizabeth Y Kim William R Mac Kenzie Jason E Stout Lois Diem John L Johnson Sebastien Gagneux Philip C Hopewell Midori Kato-Maeda Tuberculosis Trials Consortium Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS ONE |
| title | Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. |
| title_full | Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. |
| title_fullStr | Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. |
| title_full_unstemmed | Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. |
| title_short | Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. |
| title_sort | influence of m tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010753&type=printable |
| work_keys_str_mv | AT payamnahid influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT erinebliven influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT elizabethykim influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT williamrmackenzie influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT jasonestout influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT loisdiem influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT johnljohnson influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT sebastiengagneux influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT philipchopewell influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT midorikatomaeda influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis AT tuberculosistrialsconsortium influenceofmtuberculosislineagevariabilitywithinaclinicaltrialforpulmonarytuberculosis |